Aurinia alleges that Tidmarsh’s statements were not only inaccurate but also motivated by a personal vendetta against Kevin Tang, Chair of Aurinia’s board and manager of Tang Capital Partners, the company’s largest shareholder.
FDA Official Quits After Suit Alleges He Has Vendetta Against Drug Company
The American Lawyer3 hrs ago
109


Local News in Kentucky
Raw Story
AlterNet
Salon